Biology Reference
In-Depth Information
114. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro
repair of oxidative DNA damage by human nucleotide excision
repair system: possible explanation for neurodegeneration in
xeroderma pigmentosum patients. Proc Natl Acad Sci USA
1997;
94
:9463
135. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature
2004;
432
:316
23.
136. Zhan Q, Antinore MJ, Wang XW, et al. Association with Cdc2 and
inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated
protein Gadd45. Oncogene 1999;
18
:2892
e
8.
115. Lindahl T. Instability and decay of the primary structure of DNA.
Nature 1993;
362
:709
900.
137. Wang XW, Zhan Q, Coursen JD, et al. GADD45 induction of
a G2/M cell cycle checkpoint. Proc Natl Acad Sci, USA
1999;
96
:3706
e
e
15.
116. Camenisch U, Naegeli H. Role of DNA repair in the protection
against genotoxic stress. EXS 2009;
99
:111
e
11.
138. Adamson AW, Beardsley DI, Kim WJ, Gao Y, Baskaran R,
Brown KD. Methylator-induced, mismatch repair-dependent G2
arrest is activated through Chk1 and Chk2. Mol Biol Cell
2005;
16
:1513
e
50.
117. Lindahl T, Wood RD. Quality control by DNA repair. Science
1999;
286
:1897
e
905.
118. Allan JM, Engelward BP, Dreslin AJ, Wyatt MD, Tomasz M,
Samson LD. Mammalian 3-methyladenine DNA glycosylase
protects against the toxicity and clastogenicity of certain
chemotherapeutic DNA cross-linking
e
26.
139. Adamson AW, Kim WJ, Shangary S, Baskaran R, Brown KD.
ATM Is Activated in Response to N-Methyl-N'-nitro- N-nitro-
soguanidine-induced DNA Alkylation. J Biol Chem 2002;
277
:
38222
e
agents. Cancer Res
73.
119. Engelward BP, Dreslin A, Christensen J, Huszar D, Kurahara C,
Samson L. Repair-deficient 3-methyladenine DNA glycosylase
homozygous mutant mouse cells have increased sensitivity to
alkylation-induced chromosome damage and cell killing. EMBO J
1996;
15
:945
1998;
58
:3965
9.
140. Hirose Y, Berger MS, Pieper RO. Abrogation of the Chk1-
mediated G(2) checkpoint pathway potentiates temozolomide-
induced toxicity in a p53-independent manner
e
e
in human
9.
141. Beardsley DI, Kim WJ, Brown KD. N-methyl-N'-nitro-N-nitro-
soguanidine activates cell-cycle arrest through distinct mecha-
nisms activated in a dose-dependent manner. Mol Pharmacol
2005;
68
:1049
glioblastoma cells. Cancer Res 2001;
61
:5843
e
52.
120. Paik J, Duncan T, Lindahl T, Sedgwick B. Sensitization of human
carcinoma cells to alkylating agents by small interfering RNA
suppression of 3-alkyladenine-DNA glycosylase. Cancer Res
2005;
65
:10472
e
60.
142. Caporali S, Falcinelli S, Starace G, et al. DNA damage induced by
temozolomide signals to both ATM and ATR: role of
e
7.
121. Ibeanu G, Hartenstein B, Dunn WC, et al. Overexpression of
human DNA repair protein N-methylpurine-DNA glycosylase
results in the increased removal of N-methylpurines in DNA
without a concomitant increase in resistance to alkylating agents
in Chinese hamster ovary cells. Carcinogenesis 1992;
13
:1989
e
the
mismatch repair system. Mol Pharmacol 2004;
66
:478
91.
143. Yoshida K, Komatsu K, Wang HG, Kufe D. c-Abl tyrosine kinase
regulates the human Rad9 checkpoint protein in response to
DNA damage. Mol Cell Biol 2002;
22
:3292
e
95.
122. Fishel ML, Seo YR, Smith ML, Kelley MR. Imbalancing the DNA
base excision repair pathway in the mitochondria; targeting and
overexpressing N-methylpurine DNA glycosylase in mitochon-
dria leads to enhanced cell killing. Cancer Res 2003;
63
:608
300.
144. Puri PL, Bhakta K, Wood LD, Costanzo A, Zhu J, Wang JY. A
myogenic differentiation checkpoint activated by genotoxic
stress. Nat Genet 2002;
32
:585
e
e
93.
145. Yuan L, Yu WM, Yuan Z, Haudenschild CC, Qu CK. Role of SHP-
2 tyrosine phosphatase in the DNA damage-induced cell death
response. J Biol Chem 2003;
278
:15208
e
15.
123. Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T,
Sedgwick B. Reversal of DNA alkylation damage by two human
dioxygenases. Proc Natl Acad Sci, USA 2002;
99
:16660
e
16.
146. Hantschel O, Superti-Furga G. Regulation of the c-Abl and Bcr-
Abl tyrosine kinases. Nat Rev Mol Cell Biol 2004;
5
:33
e
5.
124. Aas PA, Otterlei M, Falnes PO, et al. Human and bacterial
oxidative demethylases repair alkylation damage in both RNA
and DNA. Nature 2003;
421
:859
e
44.
147. Silberman I, Sionov RV, Zuckerman V, et al. T cell survival and
function requires
e
63.
125. Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node
in the battle against genotoxicity, carcinogenicity and apoptosis
induced by alkylating agents. DNA Repair (Amst) 2007;
6
:1079
the
c-Abl
tyrosine kinase. Cell Cycle
e
57.
148. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM.
c-Abl is activated by growth factors and Src family kinases and
has a role in the cellular
2008;
7
:3847
e
99.
126. Ringvoll J, Nordstrand LM, Vagbo CB, et al. Repair deficient mice
reveal mABH2 as the primary oxidative demethylase for repair-
ing 1meA and 3meC lesions in DNA. EMBO J 2006;
25
:2189
e
response to PDGF. Genes Dev
11.
149. Plattner R, Irvin BJ, Guo S, et al. A new link between the c-Abl
tyrosine kinase and phosphoinositide signalling through PLC-
gamma1. Nat Cell Biol 2003;
5
:309
1999;
13
:2400
e
98.
127. Karran P, Bignami M. DNA damage tolerance, mismatch repair
and genome instability. Bioessays 1994;
16
:833
e
9.
128. Wang JY, Edelmann W. Mismatch repair proteins as sensors of
alkylation DNA damage. Cancer Cell 2006;
9
:417
19.
150. Mitra S, Beach C, Feng GS, Plattner R. SHP-2 is a novel target of
Abl kinases during cell proliferation. J Cell Sci 2008;
121
:3335
e
e
8.
129. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW.
Participation of p53 protein in the cellular response to DNA
damage. Cancer Res 1991;
51
:6304
46.
151. Shafman T, Khanna KK, Kedar P, et al. Interaction between ATM
protein and c-Abl
e
e
in response to DNA damage. Nature
3.
152. Kim WJ, Rajasekaran B, Brown KD. MLH1- and ATM-dependent
MAPK signaling is activated through c-Abl in response to the
alkylator N-methyl-N'-nitro-N'-nitrosoguanidine.
1997;
387
:520
11.
130. Fishel R. Signaling mismatch repair
e
e
in cancer. Nat Med
41.
131. Fishel R. The selection for mismatch repair defects in hereditary
nonpolyposis colorectal cancer: revising the mutator hypothesis.
Cancer Res 2001;
61
:7369
1999;
5
:1239
e
J Biol Chem
31.
153. Papathanasiou MA, Kerr NC, Robbins JH, et al. Induction by
ionizing radiation of the gadd45 gene in cultured human cells:
lack of mediation by protein kinase C. Mol Cell Biol
1991;
11
:1009
2007;
282
:32021
e
74.
132. Yoshioka K, Yoshioka Y, Hsieh P. ATR kinase activation mediated
by MutSalpha and MutLalpha in response to cytotoxic O6-
methylguanine adducts. Mol Cell 2006;
22
:501
e
10.
133. Zhou BB, Elledge SJ. The DNA damage response: putting
checkpoints in perspective. Nature 2000;
408
:433
16.
154. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA.
GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors
with a role in S and G2/M cell cycle checkpoints induced by
genotoxic stress. J Cell Physiol 2002;
192
:327
e
e
9.
134. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control
and cancer. Cancer Cell 2003;
3
:421
e
e
9.
e
38.
